Current Report Filing (8-k)
August 04 2022 - 4:12PM
Edgar (US Regulatory)
0001844392
false
0001844392
2022-08-04
2022-08-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported):
August 4, 2022
MARPAI, INC.
(Exact name of registrant as specified in its charter)
001-40904
(Commission
File Number)
Delaware |
86-1916231 |
(State or other jurisdiction of
incorporation) |
(I.R.S. Employer Identification No.) |
5701
East Hillsborough Avenue, Suite 1417,
Tampa, Florida
33610
(Address of principal executive offices, with zip
code)
(646) 303-3483
(Registrant's telephone number, including area
code)
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see
General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of
the Act:
Title of each class |
Ticker symbol(s) |
Name of each exchange on which
registered |
Class A Common Stock, par value $0.0001 per share |
MRAI |
The Nasdaq Capital Market |
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 8.01 Other Events.
On
August 4, 2022, Marpai, Inc. (“Marpai” or the “Company”) issued a press release announcing it has signed
a definitive agreement to acquire Maestro Health, LLC. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated
by reference herein.
Item 9.01 Financial Statements
and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: August 4, 2022 |
By: |
/s/ Edmundo Gonzalez |
|
Name: |
Edmundo Gonzalez |
|
Title: |
Chief Executive Officer |
Marpai (NASDAQ:MRAI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Marpai (NASDAQ:MRAI)
Historical Stock Chart
From Apr 2023 to Apr 2024